The European research initiative EPAD targets to improve the understanding of the early phases of Alzheimer's disease and to develop provisions which contribute to the prevention of Alzheimer.

Project duration

January 2015 to December 2019

This work has received support from the EU/EFPIA Innovative Medicines Initiative Joint Undertaking EPAD (grant n° 115736).